Italy· 033190036
NEKACIN*1 fiala IM EV 1 g 4 ml
A amikacin product containing amikacina, registered in Italy by NEW RESEARCH Srl, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Amikacin is registered in 3 of 19 countries.
Countries holding a registration under ATC S01AA21 (amikacin), each read from that country’s own register.
- This record: Italy
- 2 of them publish a price we can compare per daily dose
Amikacin · ATC S01AA21
3 / 19 countries
- Italyprice
- Polandprice
- United Kingdom
The record
At a glance
- Active substance
- Amikacina
- Manufacturer
- NEW RESEARCH Srl
- Country
- Italy (IT)
- ATC code
- S01AA21
- ATC class
- Amikacin
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic033190036NEKACIN*1 fiala IM EV 1 g 4 mlEUR 6.88
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amikacin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMIKACIN B. BRAUNB. Braun Melsungen AG, Melsungen
- United KingdomAmikacin 2.5% eye drops preservative freeSpecial Order
- United Statesamikacin sulfateSagent Pharmaceuticals
- BelgiumAmikacine B. Braun 10 mg/mlB. Braun Melsungen
- PolandAmikacin AdamedAdamed Pharma S.A.
- SpainAMICACINA B BRAUN 10 mg/ml SOLUCION PARA PERFUSION INTRAVENOSAB Braun Medical S.A.
- FinlandAmikacin Afortas2Care4 Generics ApS
- FranceAMIKACINE PANPHARMA 250 mg/mL, solution injectablePANMEDICA
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Amikacin B. Braun
- Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
- Bulgaria · Amikacin Kabi, Амикацин Б. Браун
- Cyprus · Amika-Synto, Amikacin Vioser
- Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
- Germany · Amikacin B. Braun, Amikacin Eberth
- Denmark · Amikacin Afortas, Amikacin Macure
- Estonia · Amikacin B. Braun
- Spain · Amicacina, Amicacina B. Braun
- Finland · Amikacin Afortas, Amikacin Macure
- France · Amikacine B. Braun, Amikacine Kabi
- United Kingdom (Northern Ireland) · Amikacin Demo Pharma Uk, Amikacin Galvany Pharma
- Greece · Amicasil, Amikacin Anfarm
- Croatia · Amikacin Zentiva
- Hungary · Amikacin Anfarm, Amikacin B. Braun
- Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
- Iceland · Arikayce Liposomal
- Liechtenstein · Arikayce Liposomal
- Lithuania · Biodacyna
- Luxembourg · Amikacin B. Braun, Amukin
- Latvia · Amikacin B.Braun
- Malta · Amikacin Tillomed Laboratories, Uzix
- Netherlands · Amikacine Hospira
- Norway · Amikacin Afortas, Amikacin Macure
- Poland · Amikacin B. Braun, Amikacin Kabi,
- Portugal · Amicacina Hikma, Amicacina Kabi
- Romania · Amikacin Noridem, Amikacină Atb
- Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
- Slovenia · Amikacin Kabi
- Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55a610c9-2fb1-4729-8dc2-d44a71183dbc GET /v1/drugs/55a610c9-2fb1-4729-8dc2-d44a71183dbc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 6.88,
"source": "aifa",
"currency": "EUR",
"strength": "AMIKACINA 1.000MG 1 UNITA' USO PARENTERALE",
"substance": "Amikacina",
"equivalence_group": "42D",
"transparency_flag": "X"
}See everything about amikacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.